PeptideDB

Bivatuzumab

CAS No.: 214559-60-1

Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
In vitro 在10 μg/mL的浓度下,Bivatuzumab能够标记STS细胞中的CD44v6 [1]。
Synonyms BIWA 4
molecular weight N/A
CAS 214559-60-1
Storage store at low temperature | store at -80°C
References 1. Leuci V,et al. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. 2018 Feb 15;7(5):e1423167.